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The Rv0805 gene in Mycobacterium tuberculosis encodes a metallophosphoesterase which shows cAMP-
hydrolytic activity. Overexpression of Rv0805 has been used as a tool to lower intracellular cAMP levels
and thereby elucidate the roles of cAMP in mycobacteria. Here we show that levels of cAMP in
M. tuberculosis were lowered by onlyw30% following overexpression of Rv0805, and transcript levels of
a number of genes, which include those associated with virulence and the methyl citrate cycle, were
altered. The genes that showed altered expression were distinct from those differentially regulated in a
strain deleted for the cAMP-receptor protein (CRPMt), consistent with the relatively low dependence on
cAMP of CRPMt binding to DNA. Using mutants of Rv0805 we show that the transcriptional signature of
Rv0805 overexpression is a combination of catalysis-dependent and independent effects, and that the
structurally ﬂexible C-terminus of Rv0805 is crucial for the catalysis-independent effects of the protein.
Our study demonstrates the dissociation of Rv0805 and cAMP-regulated gene expression, and reveals
alternate functions for this phosphodiesterase from M. tuberculosis.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
Cyclic adenosine monophosphate (cAMP) is a key modulator of
bacterial physiology regulating a variety of processes ranging from
carbon metabolism to virulence. Bacteria of the genus Mycobacte-
rium, including the pathogen Mycobacterium tuberculosis, are
known to produce and secrete large amounts of cAMP during
planktonic growth.1,2 Intracellular cAMP levels in mycobacteria are
also modulated by growth conditions such as pH,1,3 membrane
perturbation1 and nutrient content,1 providing evidence for the
signaling potential of this second messenger. The roles of cAMP in
colonization of the host byM. tuberculosis4,5 suggest that a study of
cAMP-signaling mechanisms in mycobacteria is relevant.
The genome ofM. tuberculosis H37Rv codes for 16 biochemically
diverse adenylyl cyclases6,7, of which Rv0386,8 Rv1264,9 Rv1625c,10
Rv1900c,11 Rv2212,12 Rv1647,13 Rv1318c, Rv1319c, Rv1320c andReproduction, Development
of Science, Bangalore 560012,
.
.in, s.sandhya@gmail.com
r Ltd. Open access under CC BY license.Rv364514 have activity in vitro. Domain composition and data
on activators and inhibitors of these proteins suggest that cAMP
synthesis by these enzymes is regulated by a variety of environ-
mental cues such a fatty acids,12 polyphosphates15 and pH.16 Ten
putative cAMP-binding proteins, which act as effectors of cAMP-
signaling, are also encoded by M. tuberculosis H37Rv.6,7 Character-
ized among these are the cAMP-regulated protein acetylase,
Rv0998,17 and the cAMP-regulated CRP-like transcription factors
Rv367618 and Rv1675c.3 Of the two CRP-like transcription factors in
M. tuberculosis direct binding of cAMP has been demonstrated only
for Rv367619 (henceforth CRPMt). Elucidation of the CRPMt regulon
in M. tuberculosis18,20 and other mycobacteria,21 coupled with
transcriptomic proﬁling of M. tuberculosis deleted for CRPMt, have
identiﬁed several target genes regulated by this protein, such as the
resuscitation promoting factor rpfA, the transcription factor whiB1
and the espACD genes, components of the ESX-1 secretion sys-
tem.20,22 In accordance with its role as a master regulator of gene
expression,M. tuberculosis deleted for CRPMt showed compromised
growth in vitro.20 Recent studies show that this effect of CRPMt
deletion could in part be attributed to serine auxotrophy.23 CRPMt
deletion also resulted in compromised virulence ofM. tuberculosis20
highlighting the critical importance of this transcription factor in
mycobacterial physiology and pathogenesis.
The role of cAMP phosphodiesterases (like cpdA from Escherichia
coli) in modulating intracellular cAMP levels in multiple species of
Table 1
List of strains and plasmids used in this study.
Description Reference
or source
M. tuberculosis strains
M. tuberculosis H37Rv Wild type M. tuberculosis
M. tuberculosis-VC M. tuberculosis harboring
pMV-empty vector
This study
M. tuberculosis-
Rv0805
M. tuberculosis harboring
pMV-Rv0805prom-Rv0805
This study
M. tuberculosis-N97A M. tuberculosis harboring
pMV-Rv0805prom-Rv0805N97A
This study
M. tuberculosis-
N97A(1e278)
M. tuberculosis harboring
pMV-Rv0805prom-Rv0805
(1-278)N97A
This study
Mycobacterial shuttle plasmids
pMV-empty vector pMV10-25 derivative used as
control
pMV-Rv0805prom-
Rv0805
pMV10-25 derivative used for
overexpression of Rv0805 under
its own promoter
This study
pMV-Rv0805prom-
Rv0805N97A
pMV10-25 derivative used for
overexpression of Rv0805N97A
under the Rv0805 promoter
This study
pMV-Rv0805prom-
Rv0805(1-278)
N97A
pMV10-25 derivative used for
overexpression of Rv0805(1-278)
N97A under the Rv0805 promoter
This study
Table 2
List of primers used in this study.
Primer name Sequence
Rv0805promfwd 50 ATCTCTAGACGACTGTGATCGCGGGGTCG 30
rrs-qRTF 50 AAGAAGCACCGGCCAACTAC 30
rrs-qRTR 50 TCGCTCCTCAGCGTCAGTTA 30
whiB7RTfwd 50 GGTGATCCCGATCTGTGGTT 30
whiB7RTrev 50 TCACACACAGTGTCTTGGCTACCT 30
icl1RTfwd 50 CAGCACATCCGCACTTTGAC 30
icl1RTrev 50 ATCACCACCGTGGGAACATC 30
Rv1130RTfwd 50 CTGATCCGCGGTCTGGTAA 30
Rv1130RTrev 50 CAGATTCCGCGGGTTAGGT 30
Rv2057cRTfwd 50 CGCAAGAACCGCCGTAAT 30
Rv2057cRTrev 50 CGCAGGATCGGGTCGTATT 30
cydARTfwd 50 GCAGCAGCCGATGAAGATG 30
cydARTrev 50 CGTCAGGACAGAGAAGTTTGGA 30
esxGRTfwd 50 GATGCTCATATCCCACAGTTGGT 30
esxGRTrev 50 CGACTCCCCCTGGTGAAAC 30
Rv1318cRTfwd 50 ACACTCTACGGCCTGATCAACA 30
Rv1318cRTrev 50 CGAACTCGGTATGCAGATAGGTT 30
rpfERTfwd 50 TGGTCGATCAACACCGGTAA 30
rpfERTrev 50 CTCAGCCACCCGGATCTG 30
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genes that encode nucleotidyl cyclases in mycobacteria, only a
single cAMP phophodiesterase, coded by the Rv0805 gene,
was identiﬁed in the genome of M. tuberculosis H37Rv.27 This gene
has close orthologs only in genomes of bacteria from the
M. tuberculosis-complex, and is absent from the genomes of fast
growing mycobacteria. In vitro biochemical characterization
showed that Rv0805 is an active phosphodiesterase capable of
hydrolyzing not only 3050-cAMP, but also other substrates such as
2030-cAMP and bis-p-nitrophenol phosphate.28 Structural and
biochemical evidence have highlighted the importance of metal
binding in catalysis, and identiﬁed Asn97, a metal binding residue
in the active site of Rv0805, as being critical for cAMP hydrolysis
in vitro28,29 and in cellulo.28 The structurally ﬂexible C-terminus of
Rv0805, while not essential for catalysis, is involved in building the
active site of Rv0805, since deletion of the C-terminus resulted in
poorer utilization of linear phosphodiester substrates.28
Overexpression of full length Rv0805(1e318) in M. tuberculosis
has been used to lower cAMP levels in cells, in order to elucidate the
role of bacterially derived cAMP in attenuating the response of the
macrophage.4 We have reported earlier that overexpression of
Rv0805(1e318) inMycobacterium smegmatis28 did indeed lead to a
decrease in intracellular cAMP levels, demonstrating the activity of
this enzyme against cAMP in vivo. However, Rv0805 overexpression
inM. smegmatis also resulted in increased sensitivity to factors that
perturbed the cell wall.28 Curiously, this phenotype was indepen-
dent of the cAMP-hydrolytic activity of Rv0805, since over-
expression Rv0805(1-278), that lacks the C-terminus of Rv0805 but
is still capable of hydrolyzing cAMP, did not result in this
phenotype.28
In this study we show that Rv0805 overexpression elicits a
transcriptional response that is independent of its ability to hy-
drolyze cAMP. The gene expression proﬁle in Rv0805 over-
expression strains differs from that seen in the DCRPMt strain,
indicating a divergence in the functions of these two proteins, and
possible catalysis-independent functions of this phosphodiesterase.
2. Material and methods
2.1. Strains and plasmids
M. tuberculosisH37Rv strains and plasmids used in this study are
listed in Table 1. M. tuberculosis H37Rv was grown in Dubos Me-
dium (supplemented with 5% Dubos Medium albumin and 0.2%
glycerol) in roller bottles at 37 C. Hygromycin B was included at a
ﬁnal concentration of 50 mg/mL wherever necessary.
2.2. Overexpression of Rv0805 in M. tuberculosis
The Rv0805 gene along with its promoter was ampliﬁed from
the genome of M. tuberculosis H37Rv by PCR using primers
Rv0805promfwd (Table 2) and Rv0805rvs.27 The PCR product was
digested with XbaI and SacI to yield a fragment (fragment I) con-
taining the Rv0805 promoter and part of the protein coding region
of the gene and cloned into similarly digested pBKS-II(þ) vector to
yield pBKS-Rv0805-fragment I. The sequence of the cloned frag-
ment was conﬁrmed. Fragment I was then released using XbaI and
SacI and ligated, along with a SacIeHindIII digested fragment
derived from pPRO-Rv08051-318,27 into XbaI and HindIII cut pMV-
10-25 to yield pMV-Rv0805prom-Rv0805. Mutants Rv0805N97A
and Rv0805(1-278)N97A were cloned similarly using the SacIe
HindIII fragments from pBKS-Rv0805N97A and pBKS-Rv0805(1-
278)N97A plasmids respectively. All plasmids were electro-
porated into electrocompetent M. tuberculosis H37Rv and trans-
formants were selected on hygromycin containing 7H10 agar.Transformed bacteriawere grown in Dubos broth in roller bottles at
37 C. Rv0805 overexpression was conﬁrmed by Western blotting
using lysates from mid-log phase cultures. Equal protein (20e
50 mg) from lysates of all strains was subjected to SDS-PAGE and
blotted onto polyvinylidene diﬂuoride membranes (Millipore).
Rv0805-speciﬁc monoclonal antibody culture supernatants28 or
Rv0805-speciﬁc polyclonal antiserumwere used at 1:50 or 1:5000
dilution respectively. Bound antibody was detected using chem-
iluminescence (ECL Plus, GE Healthcare).
2.3. Measurement of cAMP levels in M. tuberculosis
For measurement of intracellular cAMP levels, M. tuberculosis
harboring plasmids overexpressing Rv0805 or the empty vector
were grown in Dubos broth. Aliquots were taken during the loga-
rithmic phase of growth and centrifuged to separate cells from the
growth medium. Cell pellets were resuspended in 0.1 N HCl and
heated for 5 min at 95 C. Samples were stored at 70 C until
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cAMP-ELISA kit (Enzo Life Science) according to the manufacturer’s
instructions or by radioimmunoassay as described earlier.1
2.4. Transcription analysis using DNA microarrays
M. tuberculosis strains harboring Rv0805 overexpression con-
structs or empty vector were grown in Dubos broth in roller bottles
at 37 C. Bacteria were harvested at mid-log phase (light trans-
mittance at 600 nm w 0.6). Total RNA was extracted using a Fast
RNA Pro Blue kit (MP Biomedicals). RNA was treated with RNase-
free DNase (Promega) and puriﬁed using RNAeasy columns (Qia-
gen) according to the manufacturer’s instructions. Fluorescently
labeled cDNA was generated from total RNA (5e10 mg) by direct
incorporation of Cy3- or Cy5-dCTP (GE Healthcare) using Super-
script II Reverse Transcriptase (Invitrogen Life Technologies) in the
presence of random hexamers (3 mg), dNTPs (185 mM dCTP and
463 mM each of dATP, dGTP and dTTP) and Cy3-dCTP or Cy5-dCTP
(1.7 nmoles). RNA and random hexamers were initially mixed,
made up to a volume of 11 mL and heated to 95 C for 5 min. The
mixturewas then chilled on ice for 2min. Remaining components of
the reverse transcriptase reaction were added and the mixture was
incubated for 10min at 25 C, followed by 42 C for 90min. Samples
to be compared were mixed and the labeled cDNA was puriﬁed
using MinElute PCR puriﬁcation columns (Qiagen). M. tuberculosis
whole genome microarray slides (prepared at St. George’s, Univer-
sity of London) were initially prehybridized in 3.5 SSC, 0.1% SDS
and 10 mg/mL BSA for 20 min at 65 C and then washed with
deionized water and isopropanol. Labeled samples were heated for
2 min at 95 C in 4xSSC and 0.3% SDS and hybridized on microarray
slides under Lifter Slips (Thermo Scientiﬁc) for 16e20 h at 65 C in a
dark hybridization chamber. Hybridized slides were washed once
with 1XSSC, 0.05% SDS at 65 C and then twice with 0.06xSSC at
room temperature. Washed slides were dried by centrifugation and
scanned for ﬂuorescencewith a GenePix 4000Bmicroarray scanner.
Grids were ﬁtted to the raw microarray images, and background
normalization and spot quantitation was performed using Bluefuse
software (BlueGnome Ltd., Cambridge, United Kingdom) and
normalized readings were plotted using GeneSpring 10 software
(Silicon Genetics). Data were obtained for six slides, including dye
swaps, from three bacterial cultures. Data were initially ﬁltered on
expression and the lower 20th percentile was eliminated from the
analysis. Genes that showed >2-fold change in absolute expression
with a p-value <0.05 (Student’s t-test) were considered to be
altered. Raw data from microarrays for the CRPMt knockout pub-
lished previously20,22 were re-analyzed similarly for comparison
with the Rv0805 overexpression data set.
2.5. Microarray data accession numbers
Fully annotated microarray data have been deposited in
BmG@Sbase (accession number E-BUGS-146; http://bugs.sgul.ac.uk/
E-BUGS-146) and also ArrayExpress (accession number E-BUGS-
146). The array design is available in BmG@Sbase (Accession No. A-
BUGS-23; http://bugs.sgul.ac.uk/A-BUGS-23) and also ArrayEx-
press (Accession No. A-BUGS-23).
2.6. Real-time quantitative PCR
Real-time quantitative PCR was carried out using SYBR Green
Master Mix (Applied Biosystems) on an ABI Prism 7700 Sequence
detection system. rrs, coding for 16S rRNA, was used for normali-
zation. Primers used in this study are listed in Table 2. Gene speciﬁc
primers for Real-time PCR analysis were designed using the Primer
Express software (PE Applied Biosciences).3. Results
3.1. Overexpression of Rv0805 in M. tuberculosis under its
endogenous promoter
We initially attempted to overexpress Rv0805 in M. tuberculosis
under the Mycobacterium bovis hsp60 promoter, but found sub-
stantial heterogeneity in the level of overexpression between
transformants. Overexpression was also temporally unstable (not
shown). As an alternative to the hsp60 promoter, we therefore
chose to overexpress Rv0805 under its own promoter. The region
upstream of Rv0805 (w500 bps) has been used previously to
overexpress the adenylyl cyclase Rv1264 in M. bovis BCG and
M. tuberculosis.3 Since the promoter region used in this earlier
study3 contained a large part of the Rv0804 open reading frame, we
attempted to use a shorter DNA sequence limited to the intergenic
region between Rv0805 and Rv0804 (w150 bps) to overexpress
Rv0805 from a multi-copy plasmid. Immunoblotting conﬁrmed
consistent overexpression of Rv0805 in M. tuberculosis from three
independent transformants (Figure 1A). The intracellular cAMP
level was reduced on expression of Rv0805 compared to control
bacteria (Figure 1B), and the extent of reduction in intracellular
cAMP wasw30%, in agreement with earlier observations.4,28
3.2. Transcriptional changes on overexpression of Rv0805
Rv0805 overexpression in M. tuberculosis has been used previ-
ously to reduce intracellular cAMP levels.4 It was also demonstrated
that infection with Rv0805 overexpressing M. tuberculosis elicited
lower phosphorylation of CREB and impaired TNF-a production by
macrophages, in comparison with wild type bacteria,4 suggesting a
reduced immunomodulatory capacity of this strain. In order to
understand the nature of pathways perturbed by Rv0805 over-
expression in M. tuberculosis, we analyzed the transcriptome of
M. tuberculosis overexpressing Rv0805 (M. tuberculosis-Rv0805).
M. tuberculosis harboring the empty vector (M. tuberculosis-VC) was
used as the reference strain. Rv0805 transcript levels were 36-fold
higher in M. tuberculosis-Rv0805 than M. tuberculosis-VC, thus
validating its overexpression (see also Figure 1A, 3A). Additionally,
transcript levels of 107 genes were altered signiﬁcantly
(Supplementary Table 1) of which 88 (84%) were down-regulated
in M. tuberculosis-Rv0805. Using quantitative RT-PCR, the tran-
script levels of six representative genes were analyzed and found to
be in agreement with results from our microarray analysis
(Figure 1C).
Differentially regulated genes (which we call Gene List 1) were
classiﬁed on the basis of functional categories as annotated by
Tuberculist30 (Figure 1D). While no overwhelming bias was
observed, genes involved in ‘intermediary metabolism and
respiration’ appeared to be highly represented (21%) in this gene
cohort. In addition ‘cell wall and cell processes’ related genes
(19%) also showed altered regulation upon overexpression of
Rv0805.
3.3. Rv0805 induced transcriptional dysregulation is independent
of the cAMP-CRPMt pathway
In order to correlate altered gene expression in M. tuberculosis-
Rv0805 with reduced intracellular cAMP levels, we compared our
data set (Gene List 1) with genes dysregulated in a CRPMt knockout
strain.20,22 Since CRPMt is a cAMP-regulated transcription factor, it
was expected that similar genes would be dysregulated upon
deletion of CRPMt and cAMP-depletion by overexpression of
Rv0805. However, there was a poor correlation (p-value 0.49)
between the CRPMt regulon and results from the Rv0805
Figure 1. Overexpression of Rv0805 elicits changes in gene expression. A. Conﬁrmation of Rv0805 overexpression in M. tuberculosis by immunoblotting using Rv0805-speciﬁc
antibodies. Equal amounts of protein from cell lysates of strains containing empty vector (Control) or Rv0805 overexpression constructs (Rv0805) were used for western blotting.
Robust overexpression of wild type Rv0805 was observed in three independent transformants (colonies A, B, C). B. Measurement of intracellular cAMP levels in M. tuberculosis
overexpressing Rv0805 (Rv0805) compared to the empty vector (control). Bacterial cAMP was measured in the exponential phase of growth (Light transmittance at 600 nmw 0.6).
Expression of wild type Rv0805 led to decreased intracellular cAMP levels. Mean  SEM of measurements done in triplicates from three independent biological replicates is plotted.
C. Validation of microarray results by qRT-PCR was performed for three up-regulated (Rv1623c, Rv0287 and Rv2057c) and three down-regulated genes (Rv3197A, Rv1318c and
Rv0467). rrs, coding for 16S rRNA, was used as the normalizing gene. Bars represent mean  SEM of expression level of genes inM. tuberculosis-Rv0805 relative toM. tuberculosis-VC
as measured from triplicate cultures. Numbers in parentheses represent fold regulation frommicroarray results. D. Analysis of cellular pathways affected by Rv0805 overexpression.
Genes with altered expression levels (>2 fold) on expression of Rv0805 were assigned functional categories according to Tuberculist (www.tuberculist.epﬂ.ch) annotation.
Numbers represent percentage of total altered genes.
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observation none of the genes showing altered expression in
M. tuberculosis-Rv0805 had predicted upstream CRPMt binding
sites.18,21,22 In addition, the cellular pathways affected in the CRPMt
deletion strain differed from those affected on Rv0805 over-
expression (Figure 2B). This suggested that changes in transcription
upon Rv0805 overexpression were independent of cAMP/CRPMt.
Closer analysis showed that none of the genes differentially regu-
lated in the CRPMt knockout strain showed signiﬁcant alteration in
expression levels upon Rv0805 overexpression (Figure 2C), and
vice-versa. Two genes Rv1623c and Rv2057c did show similar
trends in the CRPMt knockout and Rv0805 overexpression strains
(Figure 2C). However, since neither of these genes have upstream
predicted CRPMt binding sites,18,21 this may reﬂect secondary or
indirect effects. Thus, the primary effects of Rv0805 overexpression
on the cellular transcriptome were not due to perturbation of the
cAMP/CRPMt pathway.
3.4. Catalysis-dependent and independent effects of Rv0805
overexpression
We have shown earlier that Rv0805 overexpression in
M. smegmatis resulted in cell wall perturbation in a cAMP
hydrolysis-independent manner.28 To address if the observed
transcriptomic changes in the present study were dependent
on cAMP hydrolysis, we directly compared the transcriptomes
of M. tuberculosis-Rv0805 and M. tuberculosis overexpressing
Rv0805N97A (M. tuberculosis-N97A), a catalytically inactive mutant
of Rv080528 that does not reduce intracellular cAMP levels whenoverexpressed inM. smegmatis.28 Expression levels of wild type and
Rv0805N97A mutant proteins in M. tuberculosis were similar as
assessed by immunoblotting (Figure 3A), but no reduction in
intracellular cAMP levels was seen inM. tuberculosis overexpressing
Rv0805N97A (Figure 3B).
We compared Gene List 1 with the genes that were differentially
regulated in the current microarray (Gene List 2, Supplementary
Table 2). Two cohorts of genes were identiﬁable based on this
analysis (Figure 3B). The ﬁrst cohort of genes (gene set A,
Supplementary Table 4) was dysregulated in both gene lists,
implying a strict dependence on the catalytic activity of overex-
pressed Rv0805. The second cohort of genes (gene set B,
Supplementary Table 5) showed altered expression in Gene list 1
but not in Gene list 2, implying catalysis-independent effects of
Rv0805 overexpression (Figure 3C). A third set of genes were pre-
sent only in Gene List 2 but not Gene List 1 (Supplementary
Table 6), suggesting that their dysregulation was due to over-
expression of catalytically inactive Rv0805N97A alone. Most of
these genes belonged to the DosR regulon, including dosR itself.
Close inspection of the data revealed that one of the three
M. tuberculosis-Rv0805 biological replicates also showed altered
expression of this set of genes. Since the DosR regulon is induced by
multiple stresses such as hypoxia,31 exposure to ethanol and even
centrifugation32 its down-regulation in M. tuberculosis over-
expressing Rv0805 may indicate a cellular stress-response to pro-
tein overproduction. We therefore excluded these genes from
further analysis.
We analyzed Gene sets A and B in order to reveal speciﬁc
pathways affected in each case.
Figure 2. Comparison of changes in the transcriptome following Rv0805 overexpression and in the Dcrp mutant A. Comparison of Rv0805 overexpression gene set and the CRPMt
regulon.20,22 Fold regulation of 160 genes from the two data sets were compared on a scatter plot. Pearson’s correlation analysis was performed using Graphpad Prism and was
found not to be statistically signiﬁcant (p-value 0.49). B. Comparison of cellular pathways affected by Rv0805 overexpression (outer donut) and CRPMt deletion (inner donut). Genes
with altered expression levels (>2 fold) were assigned functional categories according to Tuberculist (www.tuberculist.epﬂ.ch) annotation. Numbers represent percentage of total
genes altered. C. Comparison of genes altered by Rv0805 overexpression and CRPMt deletion. Genes dysregulated upon Rv0805 overexpression (upper panel) do not show signiﬁcant
alteration in expression levels in the CRPMt knockout and vice-versa (lower panel). Red boxes indicate up-regulation and blue boxes indicate down-regulation compared to
appropriate reference strains. Numbers indicate fold change in expression level as obtained from microarray analyses. ‘-’ indicates no change in expression levels (<2.0 fold).
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3.5.1. ESX systems and metal regulated genes
The ESX-3 system, one of 5 type VII secretion systems in
M. tuberculosis was up-regulated exclusively on expression of wild
type Rv0805 (Rv0286þ2.4, Rv0287þ2.5, Rv0288þ2.7, Rv0289þ2.7,
Rv0290 þ2.5). This system is thought to play a role in metal acqui-
sition33 and is induced in low iron conditions by the IdeR transcrip-
tional regulator.34 Studies have also shown the regulation of this
operon by Zur, a zinc dependent transcription factor.35 Two other
operons regulated by Zur were also up-regulated in this category of
genes. These are esxR (Rv3019c þ2.5) and esxS (Rv3020c þ2.4),
secretedantigens similar toESAT-6andCfp-10, andRv2057c, the gene
encoding the ribosomal protein Rv2057c (Rv2057c þ7.0).35
3.6. Analysis of Gene set B
3.6.1. Cell wall associated genes
Several genes that are associated with cell wall processes were
identiﬁed in this gene set. The resuscitation promoting factor E
(rpfE; Rv2450c -6.3) showed maximal down-regulation. Rpfs are
thought to be associated with the process of reactivation of the
tubercle bacillus.36 While dispensable for growth of mycobacteria
in vitro, they are required for complete virulence in the mouse
model.36 Inparticular, rpfEwas induced by lowpHandhypoxia, both
thought to be stresses experienced byM. tuberculosis in the host.37In addition to rpfE, iniA (Rv0342 -2.6) and iniB (Rv0341 -2.8)
were also down-regulated on Rv0805 overexpression. Both of these
two genes along with iniC were identiﬁed as genes induced by
the cell wall targeting drug isoniazid.38 IniA and B are thought to
be components of a drug efﬂux system that allows increased
tolerance toward isoniazid and ethambutol.39 In addition muta-
tionswere identiﬁed in these genes in isoniazid-resistant isolates of
M. tuberculosis.40
3.6.2. Adenylyl cyclases Rv1318c and Rv1319c
Among the genes down-regulated on Rv0805 overexpression
were the adenylyl cyclases Rv1318c (-3.4) and Rv1319c (-3.1), which
along with Rv1320c form part of a putative operon. These cyclases
are membrane bound and contain a signaling HAMP domain that
regulates the activity of the cyclase domain.6,41 Transcript levels of
other adenylyl cyclases were unaltered suggesting that the down-
regulation of Rv1318c and Rv1319c was not a general response
due to perturbation of the cAMP homeostasis in the cell.
3.6.3. Genes of the methyl citrate cycle
Amongst the most highly down-regulated genes in this gene set
were Rv1129c (-5.7), Rv1130 (prpC; -9.5) and Rv1131 (prpD; -5.3).
Rv1129c is a transcriptional activator leading to enhanced tran-
scription of prpC and prpD, both components of the methyl citrate
cycle.42 In addition to these Rv0467 (icl1; -2.5), another enzyme
from the methyl citrate shunt,43 was also down-regulated. Thus
Figure 3. A. Role of the C-terminus of Rv0805 in gene expression changes. Overexpression of Rv0805N97A and Rv0805(1-278)N97A. Immunoblot for lysates of M. tuberculosis
harboring empty vector (control) or plasmid for overexpression of Rv0805, Rv0805N97A or Rv0805(1-278)N97A. Polyclonal antibodies against Rv0805 or a C-terminus speciﬁc
monoclonal antibody (1G5B5) were used to distinguish between the full length and C-terminally truncated proteins based on differential mobility and loss of immunoreactivity
respectively. B. Intracellular cAMP levels in M. tuberculosis overexpressing Rv0805, Rv0805N97A or Rv0805(1-278)N97A. Mean  SEM of at least two biological replicates are
plotted. (n.s. indicates that the two groups compared are statistically not signiﬁcant (p-value > 0.05)) C. Heat map showing expression levels of genes in M. tuberculosis-Rv0805
compared with a strain harboring empty vector (control) or overexpressing Rv0805N97A. Two distinct gene sets (A and B) are clearly discernible. D. Genes showing altered
regulation in the Rv0805 overexpression strain compared to M. tuberculosis harboring empty vector (control) or overexpressing Rv0805N97A or Rv0805(1-278)N97A. Presence
of the C-terminus of Rv0805 is essential for manifestation of catalysis-independent gene expression changes. Red boxes indicate up-regulation and blue boxes indicate
down-regulation in M. tuberculosis-Rv0805 compared to the indicated strains. Numbers indicate fold change in expression level as obtained from microarray analyses. ‘-’ indicates
no change in expression levels (<2.0 fold).
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the entire methyl citrate cycle.
3.6.4. WhiB7 and Eis
Both whiB7 (Rv3197A -5.6) and its downstream target, eis
(Rv2416c -5.3), were down-regulated in M. tuberculosis-Rv0805.
WhiB7 is one of 7 WhiB-like proteins found in M. tuberculosis, and
has been associated with tolerance toward free fatty acids and
some antimicrobials.44 Recent studies have also shown that levels
of WhiB7 in the cell are regulated by the redox potential of the
cell.45 Eis is an acetyl-transferase that when overexpressed in
M. smegmatis leads to increased virulence.46 Due to its ability to
acetylate a wide range of aminoglycosides, Eis has been linked to
resistance of XDR-TB to kanamycin.47 It has also been associated
with increased virulence of the Beijing strain of M. tuberculosis.48
The dysregulation of the whiB7-eis axis on Rv0805 over-
expression is of particular interest given the virulence-related
phenotypes of both Rv0805 deletion and overexpression. It is also
pertinent that the transcript level of these genes were altered
independently of the catalytic activity of Rv0805, reiterating that
Rv0805 overexpression may alter virulence-related pathways un-
related to its cAMP-hydrolytic ability.
3.7. Effects of the C-terminus on catalysis-dependent and
independent effects
Our earlier studies using M. smegmatis showed cAMP
hydrolysis-independent perturbation of the cell wall upon over-
expression of Rv0805.28 The ﬂexible C-terminus of the protein
mediated this phenotype as overexpression of Rv0805(1-278),
which lacks the last 40 amino acids, did not affect cell wallproperties ofM. smegmatis.28 Based on these studies we asked if the
presence of the C-terminus of Rv0805 contributed to the gene
expression changes observed in M. tuberculosis as well, by
attempting to overexpress Rv0805(1-278). We were unable to
obtain strains that overexpressed wild type Rv0805(1-278),
but were successful in obtaining a strain of M. tuberculosis over-
expressing Rv0805(1-278)N97A, conﬁrmed by western blotting by
a change in mobility of the immunoreactive protein (Figure 3A).
The absence of the C-terminus in the overexpressed protein was
further veriﬁed through a loss of immunoreactivity to amonoclonal
antibody speciﬁc for the C-terminus of Rv0805 (Figure 3A).
Rv0805(1-278)N97A overexpression did not reduce intracellular
cAMP levels in M. tuberculosis, conﬁrming that it was unable to
hydrolyze cAMP in vitro (Figure 3B).
We then compared the changes in gene expression between
M. tuberculosis-Rv0805 overexpressing strains and M. tuberculosis
expressing Rv0805(1-278)N97A. Genes that were differentially
expressed between these two strains (Gene List 3) were inspected
for the presence of genes found in gene set B. Gene set B genes
showed a similar trend in Gene list 3 as well as Gene list 1,
conﬁrming that catalysis-independent transcriptional effects of
Rv0805 overexpression required the presence of the C-terminus
of Rv0805 (Figure 3D). These results are commensurate with
earlier observations28 emphasizing the importance of the C-ter-
minus of Rv0805 in orchestrating the in vivo activities of the
protein.
4. Discussion
In this study, we have used DNA microarrays to elucidate gene
expression changes associated with overexpression of Rv0805, in
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does not alter the levels of cAMP-CRPMt regulated genes, even
though cAMP levels were reduced in cells. Moreover, the genes
dysregulated by Rv0805 overexpression do not appear to be targets
of CRPMt. Therefore, overexpression of Rv0805 in M. tuberculosis
does not directly target the cAMP pathway mediated by CRPMt, but
instead can regulate the expression of genes, independent of its
catalytic activity.
Overexpression of Rv0805 was achieved under its endogenous
promoter from a multi-copy plasmid. In addition to robust over-
expression, this strategy ensured that the overexpressed protein
was similar to the endogenous protein in terms of its translational
start site. To our knowledge such an approach to protein over-
expression in mycobacteria has not been employed previously. The
hsp60 promoter is widely used for protein overexpression in
mycobacteria, but has been shown to be unstable on occasion.49
Indeed, our own attempts at overexpressing Rv0805 under the
hsp60 promoter in M. bovis BCG met with little success (data not
shown). The Rv0805 promoter may therefore provide an alterna-
tive to the hsp60 and sigA promoters for protein overexpression in
mycobacteria.
Even though Rv0805 overexpression did lead to a reduction in
intracellular cAMP levels in M. tuberculosis, we did not ﬁnd alter-
ation in expression levels of CRPMt regulated genes. This observa-
tion reiterates differences seen between the E. coli CRP and CRPMt
for cAMP-regulated DNA binding.19 The lower afﬁnity for cAMP and
lower dependence on cAMP for DNA binding by CRPMt have been
investigated both biochemically19 and structurally.50 Indeed, higher
levels of cAMP in mycobacteria than enteric bacteria such as
E. coli1,2 may have resulted in desensitization of CRPMt to small
changes in intracellular cAMP levels. Given the moderate reduction
in cAMP levels upon overexpression of Rv0805, it is likely that
additional mechanisms to regulate intracellular cAMP, other than
the catalytic activity of Rv0805, may be operative in mycobacteria.
Since mycobacteria secrete large amounts of cAMP, efﬂux of cAMP
may be an important mechanism for modulating intracellular
cAMP levels in these bacteria. Further, the absence of direct
orthologs of Rv0805 in the genomes of fast growing mycobacteria
suggest that Rv0805 may not be primarily responsible for cAMP
hydrolysis in these bacteria.
M. tuberculosis codes for 9 other putative cAMP-responsive
proteins6 that may directly or indirectly mediate the transcrip-
tional effects of Rv0805 overexpression observed in this study.
Two of these, Rv1675c (Cmr) and Rv0998, have been character-
ized. Cmr is a transcription factor that is thought to be regulated
by cAMP; however, direct binding of cAMP to this protein has not
been demonstrated to date. Cmr is unlikely to mediate the tran-
scriptional dysregulation observed upon Rv0805 overexpression,
as known targets of Cmr (such as Rv1265, groEL2 and mdh3) were
unaffected in our experiments. Rv0998, also called KATmt, is a
cAMP-dependent protein lysine acetyltransferase.17,51 KATmt was
recently shown to acetylate several fatty acyl-CoA ligases (FadDs)
including acetyl CoA-synthetase.51 The ortholog of KATmt in
M. bovis BCG (KATbcg) appears to play a role in reducing propio-
nate toxicity, since a strain deleted for KATbcg was compromised
for growth on propionate.51 Given the dysregulation of several
genes involved in propionate metabolism in M. tuberculosis-
Rv0805, it is possible that the effects of Rv0805 overexpression in
M. tuberculosis were, at least in part, due to perturbation of KATmt
signaling.
The catalysis-dependent effects of Rv0805 overexpression
altered transcription of genes that respond to the levels of cellular
metals, alluding to a dysregulation of metal ions in the cell. Rv0805
binds Fe2þ and Mn2þ at its active site.27 This may allow it to act as
a sink or sensor for these metals in the cell, at least uponoverexpression, resulting in altered regulation of Zur/IdeR metal
dependent regulons. In agreement with this, Rv0805N97A over-
expression did not result in dysregulation of Zur/IdeR regulon
genes. The poorer binding of the mutant protein to metal ions was
revealed by crystallographic studies showing that Asn97 is involved
in Mn2þ co-ordination, and its mutation to Ala resulted in a lower
occupancy of metal in the active site.29 The implications for
possible roles of Rv0805 in regulating metal homeostasis remain to
be tested.
Among the genes dysregulated by Rv0805 overexpression in a
catalysis-independent manner, several pathways that are involved
in virulence were identiﬁable. The genes Rv1129c, prpC and prpD
and icl1 are part of the methyl citrate pathway and are essential for
the full virulence of M. tuberculosis.42 The methyl citrate pathway
plays a role in utilization of propionate derived from cholesterol52
and odd chained fatty acids.53 It has been speculated that
M. tuberculosis uses cholesterol as a carbon source in the host.54
Indeed, knockouts of prpC, prpD and icl1 show compromised
growth in bone derived macrophages and poor growth on propi-
onate in vitro.42 Interestingly, transposon insertion mutants of
methyl citrate cycle genes as well as Rv0805 were compromised in
a screen for cholesterol utilization.55 In addition, a transposon
insertion in the intergenic region between Rv0805 and Rv0804 (i.e.
in the Rv0805 promoter) in an icl1 knockout genetic background
resulted in under-representation in a TraSH screen for propionate
toxicity.56 These observations clearly indicate a link between the
methyl citrate cycle genes and Rv0805 that has not yet been
explored. Altered regulation of the transcriptional regulator whiB7
and its target eis is also of particular interest. Whib7 is thought to
play a role in resistance to fatty acids and several antibiotics. An eis-
deletion mutant also shows compromised growth on cholesterol55
further supporting the hypothesis that Rv0805 may have direct or
indirect roles in cholesterol metabolism.
The presence of the C-terminus of Rv0805 was essential for the
catalysis-independent effects of Rv0805 overexpression on the
transcriptome. This observation is in concordance with earlier
studies on the phenotypic effects of Rv0805 overexpression in
M. smegmatis, and can be attributed to the aberrant localization of
C-terminus deﬁcient Rv0805 to the cytosol, in contrast to the
membrane localization of the full length protein.28 Alternatively,
the C-terminus of Rv0805 may provide an interaction domain
allowing the recruitment of Rv0805 to appropriate complexes.
High-throughput approaches such as gene expression proﬁling
usingmicroarrays are a useful platform for investigating alterations
at the level of the whole genome. However, such methodologies
can also provide erroneous data that could affect interpretations
of biological phenomena. For example, we identiﬁed a set of
genes that appeared to be dysregulated upon overexpression of
Rv0805N97A, but not Rv0805 in M. tuberculosis (Gene List B).
Several of themaximally dysregulated genes of this group belonged
to the DosR regulon. While this result may indeed be a genuine
effect of Rv0805N97A overproduction, it is known that the DosR
regulon is induced by a variety of stresses, and indeed, by methods
used for RNA extraction.32 Perhaps protein overproduction, pre-
sumably a stressful condition for the cell, may also result in in-
duction of this regulon. However, we believe that using a
combination of high-throughput methodologies with appropriate
biochemically validated controls, such as those used in this study,
can provide robust results in understanding perturbations of
complex biological systems.
In summary, disparate gene regulation proﬁles of the Rv0805
overexpressing strain and the CRPMt knockout mutant, together
with the dysregulation of a large cohort of genes independent of
catalytic activity, suggest that the primary role of Rv0805 in the cell
may not be to regulate intracellular cAMP levels. In an earlier study,
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the importance of cAMP in the virulence ofM. tuberculosis,4 and the
reduced virulence of the overexpressing strainwas attributed to the
activity of Rv0805 as a cAMP phosphodiesterase. In the light of our
present study, we ﬁnd that this may not be entirely true, since
overexpression of Rv0805 down regulates a number of genes that
have been shown to be important for pathogenesis. The roles of
Rv0805 in the cell wall and membrane, in addition to the contri-
bution of the C-terminus of Rv0805 to this protein’s function in vivo,
need to be examined further to completely understand the mo-
lecular activities and physiological roles of this phosphodiesterase.
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